The NEAT study: A 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patientsRODRIGUEZ-FRENCH, Amalia; BOGHOSSIAN, Jack; GRAY, Glenda E et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 35, Num 1, pp 22-32, issn 1525-4135, 11 p.Article

Risk of birth defects associated with nelfinavir exposure during PregnancyCOVINGTON, Deborah L; CONNER, Susan D; DOI, Peggy A et al.Obstetrics and gynecology (New York. 1953). 2004, Vol 103, Num 6, pp 1181-1189, issn 0029-7844, 9 p.Article

Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivoCOLOMBO, Sara; SORANZO, Nicole; ROTGER, Margalida et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 9, pp 599-608, issn 1744-6872, 10 p.Article

Plasma levels of Indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patientsLE MOING, Vincent; PEYTAVIN, Gilles; JOURNOT, Valérie et al.Journal of acquired immune deficiency syndromes (1999). 2003, Vol 34, Num 5, pp 497-499, issn 1525-4135, 3 p.Article

Synthesis, anti-HIV and antitubercular activities of nelfinavir diester derivatives : Human and animal retrovirrusesSRIRAM, Dharmarajan; YOGEESWARI, Perumal; DINAKARAN, Murugesan et al.Biomedicine & pharmacotherapy. 2008, Vol 62, Num 1, pp 1-5, issn 0753-3322, 5 p.Article

Short Report: HIV Protease Inhibitors, Indinavir or Nelfinavir, Augment Antimalarial Action of Artemisinin in vitroMISHRA, Lokesh C; BHATTACHARYA, Amit; SHARMA, Manish et al.The American journal of tropical medicine and hygiene. 2010, Vol 82, Num 1, pp 148-150, issn 0002-9637, 3 p.Article

Pharmacokinetics, food intake requirements and tolerability of once-daily combinations of nelfinavir and low-dose ritonavir in healthy volunteersAARNOUTSE, R. E; DROSTE, J. A. H; VAN OOSTERHOUT, J. J. G et al.British journal of clinical pharmacology. 2003, Vol 55, Num 2, pp 115-125, issn 0306-5251, 11 p.Article

Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metaboliteDAMLE, Bharat D; UDERMAN, Howard; BISWAS, Pinaki et al.British journal of clinical pharmacology. 2009, Vol 68, Num 5, pp 682-689, issn 0306-5251, 8 p.Article

Thermal stability study of the protease inhibitors: Nelfinavir mesylate and atazanavir sulfateMICHALIK, Katarzyna; DRZAZGA, Zofia; MICHNIK, Anna et al.Journal of thermal analysis and calorimetry. 2007, Vol 88, Num 2, pp 401-404, issn 1388-6150, 4 p.Conference Paper

Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of lifeMIROCHNICK, Mark; STEK, Alice; MOFENSON, Lynne et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 2, pp 189-194, issn 1525-4135, 6 p.Article

Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLCQIUFANG JING; YONGJIA SHEN; YANHUI TANG et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 3, pp 1065-1069, issn 0731-7085, 5 p.Article

Depot-specific adipocyte cell lines reveal differential drug-induced responses of white adipocytes-relevance for partial lipodystrophyKOVSAN, Julia; OSNIS, Alexander; RUDICH, Assaf et al.American journal of physiology. Endocrinology and metabolism. 2009, Vol 59, Num 2, issn 0193-1849, E315-E322Article

Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant womenKOSEL, Bradley W; BECKERMAN, Karen P; HAYASHI, Sandra et al.AIDS (London). 2003, Vol 17, Num 8, pp 1195-1199, issn 0269-9370, 5 p.Article

Place de l'induction de tolérance chez le sujet VIH intolérant aux médicaments = Tolerance-induction protocol in HIV-infected patients with drug hypersensitivityMESSAAD, D; REYNES, J; FAUCHERRE, V et al.Revue française d'allergologie et d'immunologie clinique. 2002, Vol 42, Num 8, pp 757-762, issn 0335-7457, 6 p.Article

The Impact of Nelfinavir Exposure on Cancer Development Among a Large Cohort of HIV-Infected PatientsCRUM-CIANFLONE, Nancy F; HUPPLER HULLSIEK, Katherine; MARCONI, Vincent et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 3, pp 305-309, issn 1525-4135, 5 p.Article

Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavirBATES, Duane E; HERMAN, Robert J.The Annals of pharmacotherapy. 2006, Vol 40, Num 6, pp 1190-1195, issn 1060-0280, 6 p.Article

Pharmacokinetic evaluation and short-term activity of stavudine, nevirapine, and nelfinavir therapy in HIV-1-infected adultsSKOWRON, Gail; LEOUNG, Gifford; FISHER, Alvan et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 35, Num 4, pp 351-358, issn 1525-4135, 8 p.Article

Phase I study of nelfinavir in liposarcomaPAN, Janet; MOTT, Michelle; SYNOLD, Timothy et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 6, pp 791-799, issn 0344-5704, 9 p.Article

Selection of HIV Resistance Associated With Antiretroviral Therapy Initiated Due to Pregnancy and Suspended PostpartumELLIS, Giovanina M; HUANG, Sharon; HITTI, Jane et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 3, pp 241-247, issn 1525-4135, 7 p.Article

CYP2C19 Genetic Variants Affect Nelfinavir Pharmacokinetics and Virologic Response in HIV-1―Infected Children Receiving Highly Active Antiretroviral TherapySAITOH, Akihiko; CAPPARELLI, Edmund; SPECTOR, Stephen A et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 3, pp 285-289, issn 1525-4135, 5 p.Article

Immunotoxicity evaluation of nelfinavir in ratsBURNS-NAAS, Leigh Ann; WHITE, Kimber L; MCCAY, J. Ann et al.Human & experimental toxicology. 2005, Vol 24, Num 2, pp 67-78, issn 0960-3271, 12 p.Article

Effect of transporter modulation on the emergence of nelfinavir resistance in vitroCHANDLER, Becky; DETSIKA, Maria; OWEN, Andrew et al.Antiviral therapy (London). 2007, Vol 12, Num 5, pp 831-834, issn 1359-6535, 4 p.Article

Efficacy of nelfinavir-based treatment in the central nervous system of HIV-1 infected patientsKARLSTRÖM, Olle; STAHLE, Lars; PERRIN, Luc et al.Scandinavian journal of infectious diseases. 2006, Vol 38, Num 5, pp 371-374, issn 0036-5548, 4 p.Article

The pharmacokinetics of nelfinavir and M8 during pregnancy and post partumVAN HEESWIJK, Rolf P. G; KHALIQ, Yasmin; GALLICANO, Keith D et al.Clinical pharmacology and therapeutics. 2004, Vol 76, Num 6, pp 588-597, issn 0009-9236, 10 p.Article

Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infantsCAPPARELLI, Edmund V; SULLIVAN, John L; MOFENSON, Lynne et al.The Pediatric infectious disease journal. 2001, Vol 20, Num 8, pp 746-751, issn 0891-3668Article